Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significance of Targeted Antimicrobial Prophylaxis Using Rectal-culture Selective Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial.
Sadahira T, Sekito T, Maruyama Y, Ichikawa T, Kurihara Y, Shiraishi H, Sakuma T, Tokunaga M, Mitsui Y, Kusumi N, Tominaga Y, Katayama S, Iwata T, Nishimura S, Edamura K, Kobayashi T, Watanabe M, Hiyama Y, Yamada H, Kurata H, Kondo T, Mitsui M, Takenaka T, Kiyota H, Araki M, Miyazaki J, Takahashi S, Yamamoto S, Wada K. Sadahira T, et al. Among authors: kusumi n. Urology. 2024 Dec 16:S0090-4295(24)01144-0. doi: 10.1016/j.urology.2024.12.018. Online ahead of print. Urology. 2024. PMID: 39694101
A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial.
Sadahira T, Maruyama Y, Hiyama Y, Kitano H, Yamada H, Goto T, Kondo T, Shigemura K, Mitsui Y, Iwata T, Edamura K, Araki M, Watanabe M, Takenaka T, Teishima J, Miyata Y, Ishikawa K, Takaoka EI, Miyazaki J, Takahashi S, Masumori N, Kiyota H, Fujisawa M, Yamamoto S, Sakuma T, Kusumi N, Ichikawa T, Watanabe T, Nasu Y, Tsugawa M, Nasu Y, Wada K. Sadahira T, et al. Among authors: kusumi n. Acta Med Okayama. 2021;75(5):663-667. doi: 10.18926/AMO/62782. Acta Med Okayama. 2021. PMID: 34703052 Free article.
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
Sadahira T, Wada K, Araki M, Ishii A, Takamoto A, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y, Kumon H; Okayama Urological Research Group (OURG). Sadahira T, et al. J Antimicrob Chemother. 2017 Feb;72(2):529-534. doi: 10.1093/jac/dkw424. Epub 2016 Oct 12. J Antimicrob Chemother. 2017. PMID: 27733519 Free article. Clinical Trial.
Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab.
Sekito T, Bekku K, Katayama S, Watanabe T, Tsuboi I, Yoshinaga K, Maruyama Y, Yamanoi T, Kawada T, Tominaga Y, Sadahira T, Iwata T, Nishimura S, Kusumi N, Edamura K, Kobayashi T, Kurose K, Ichikawa T, Miyaji Y, Wada K, Kobayashi Y, Araki M. Sekito T, et al. Among authors: kusumi n. Clin Genitourin Cancer. 2024 Aug;22(4):102097. doi: 10.1016/j.clgc.2024.102097. Epub 2024 Apr 17. Clin Genitourin Cancer. 2024. PMID: 38763123
Retroperitoneal myofibroblastoma in an 88-year-old male.
Watari S, Ichikawa T, Shiraishi H, Sakuma T, Kubota R, Kusumi N, Tsushima T, Nagakita K, Shinno Y. Watari S, et al. Among authors: kusumi n. IJU Case Rep. 2022 Jun 14;5(5):378-382. doi: 10.1002/iju5.12493. eCollection 2022 Sep. IJU Case Rep. 2022. PMID: 36090948 Free PMC article.
Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study.
Watari S, Katayama S, Shiraishi H, Tokunaga M, Kubota R, Kusumi N, Ichikawa T, Tsushima T, Kobayashi Y, Bekku K, Araki M. Watari S, et al. Among authors: kusumi n. Discov Oncol. 2023 Nov 16;14(1):204. doi: 10.1007/s12672-023-00816-x. Discov Oncol. 2023. PMID: 37968545 Free PMC article.
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab.
Katayama S, Iwata T, Kawada T, Okamoto Y, Sano Y, Kawago Y, Miyake S, Moriwake T, Kuinose A, Horikawa Y, Tsuboi K, Tsuboi I, Sakaeda K, Nakatsuka H, Takamoto A, Hirata T, Shirasaki Y, Yamasaki T, Morinaka H, Nagasaki N, Hara T, Ochi A, Okumura M, Watanabe T, Sekito T, Kawano K, Horii S, Yamanoi T, Nagao K, Yoshinaga K, Maruyama Y, Tominaga Y, Sadahira T, Nishimura S, Edamura K, Kobayashi T, Kusumi N, Kurose K, Yamamoto Y, Sugimoto M, Nakada T, Sasaki K, Takenaka T, Ebara S, Miyaji Y, Wada K, Kobayashi Y, Araki M. Katayama S, et al. Among authors: kusumi n. Urol Oncol. 2024 Mar;42(3):70.e11-70.e18. doi: 10.1016/j.urolonc.2023.11.009. Epub 2023 Dec 20. Urol Oncol. 2024. PMID: 38129282
22 results